Pharvaris NV
PHVS
$19.52
Closing
▼-2.40%
1D
▼-30.41%
YTD
PHVS
BBG00YYCW2H3
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$1.05B
Analysts' Rating
BUY
Price Target (Mean)
32.43
Total Analysts
6
P/E
Operating Margin
0.00%
Beta
-3.17
Revenue Growth
0.00%
52 week high
$33.00
52 week low
$15.37
Div. Yield
%
EPS Growth
8.40
Company Profile
Pharvaris BV is a Switzerland-based clinical-stage company. The activity of the Company focuses on producing oral bradykinin B2-receptor antagonists and is advancing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE).
